136 related articles for article (PubMed ID: 35777127)
1. Analysis of polymorphisms in EGF, EGFR and HER2 genes in pancreatic neuroendocrine tumors (PNETs).
Marinović S; Cigrovski Berković M; Zjačić-Rotkvić V; Kapitanović S
Cancer Genet; 2022 Aug; 266-267():44-50. PubMed ID: 35777127
[TBL] [Abstract][Full Text] [Related]
2. Interleukin 1β gene single-nucleotide polymorphisms and susceptibility to pancreatic neuroendocrine tumors.
Cigrovski Berković M; Catela Ivković T; Marout J; Zjačić-Rotkvić V; Kapitanović S
DNA Cell Biol; 2012 Apr; 31(4):531-6. PubMed ID: 21988351
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor receptor (EGFR) pathway genes and interstitial lung disease: an association study.
Li C; Wei R; Jones-Hall YL; Vittal R; Zhang M; Liu W
Sci Rep; 2014 May; 4():4893. PubMed ID: 24819665
[TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphisms of inflammatory response gene TNF-α and its influence on sporadic pancreatic neuroendocrine tumors predisposition risk.
Karakaxas D; Gazouli M; Coker A; Agalianos C; Papanikolaou IS; Patapis P; Liakakos T; Dervenis C
Med Oncol; 2014 Oct; 31(10):241. PubMed ID: 25213764
[TBL] [Abstract][Full Text] [Related]
5. EGF+61 A>G polymorphism is not associated with lung cancer risk in the Brazilian population.
Laus AC; de Paula FE; de Lima MA; Carlos CD; Gomes INF; de Marchi P; Valente JKN; Pioltini ABM; Miziara JE; da Silva CM; Viana LS; Scapulatempo-Neto C; Reis RM
Mol Biol Rep; 2019 Apr; 46(2):2417-2425. PubMed ID: 30783937
[TBL] [Abstract][Full Text] [Related]
6. Interaction of EGFR 497Arg>Lys with EGF +61A>G polymorphism: modulation of risk in esophageal cancer.
Upadhyay R; Jain M; Kumar S; Ghoshal UC; Mittal B
Oncol Res; 2008; 17(4):167-74. PubMed ID: 18773861
[TBL] [Abstract][Full Text] [Related]
7. Lack of Association between Epidermal Growth Factor or Its Receptor and Reflux Esophagitis, Barrett's Esophagus, and Esophageal Adenocarcinoma: A Case-Control Study.
Deissova T; Cvanova M; Kala Z; Jiraskova Zakostelska Z; Dolina J; Kunovsky L; Kroupa R; Pavlovsky Z; Lipovy B; Danek Z; Izakovicova Holla L; Urban O; Navratil V; Lischke R; Harustiak T; Grolich T; Prochazka V; Slaby O; Borilova Linhartova P
Dis Markers; 2022; 2022():8790748. PubMed ID: 36092955
[TBL] [Abstract][Full Text] [Related]
8. Essential role of polymorphism of Gab1, EGFR, and EGF for the susceptibility of biliary tract cancer.
Meng LQ
Tumour Biol; 2014 Dec; 35(12):12497-508. PubMed ID: 25217982
[TBL] [Abstract][Full Text] [Related]
9. Assessment of HER1 (rs11543848) and HER2 (rs1136201) polymorphism and their association with colorectal cancer susceptibility in Khyber Pakhtunkhwa, Pakistan.
Ullah A; Khan BM; Khan NU; Muntaha ST; Khan S; Khan AU; Almutairi MH; Ali I
Mol Biol Rep; 2023 Dec; 51(1):1. PubMed ID: 38040921
[TBL] [Abstract][Full Text] [Related]
10. EGF+61 A>G polymorphism does not predict response to first-generation EGFR tyrosine kinase inhibitors in lung cancer patients.
Leal LF; Laus AC; Cavagna R; de Paula FE; de Oliveira MA; Ribeiro DM; Hassan FM; Miziara JE; da Silva ECA; da Silva VD; De Marchi P; Reis RM
Thorac Cancer; 2020 Oct; 11(10):2987-2992. PubMed ID: 32881389
[TBL] [Abstract][Full Text] [Related]
11. Predicting Novel Drug Candidates for Pancreatic Neuroendocrine Tumors via Gene Signature Comparison and Connectivity Mapping.
Xiao Y; Xu G; Cloyd JM; Du S; Mao Y; Pawlik TM
J Gastrointest Surg; 2022 Aug; 26(8):1670-1678. PubMed ID: 35508682
[TBL] [Abstract][Full Text] [Related]
12. Single nucleotide polymorphisms of genes for EGF, TGF-β and TNF-α in patients with pancreatic carcinoma.
Zhang L; Wu G; Herrle F; Niedergethmann M; Keese M
Cancer Genomics Proteomics; 2012; 9(5):287-95. PubMed ID: 22990108
[TBL] [Abstract][Full Text] [Related]
13. The Metastasis Suppressor, N-MYC Downstream-regulated Gene-1 (NDRG1), Down-regulates the ErbB Family of Receptors to Inhibit Downstream Oncogenic Signaling Pathways.
Kovacevic Z; Menezes SV; Sahni S; Kalinowski DS; Bae DH; Lane DJ; Richardson DR
J Biol Chem; 2016 Jan; 291(3):1029-52. PubMed ID: 26534963
[TBL] [Abstract][Full Text] [Related]
14. EGF +61A>G polymorphism and gastrointestinal cancer risk: a HuGE review and meta-analysis.
Piao Y; Liu Z; Ding Z; Xu L; Guo F; Sun Q; Xie X
Gene; 2013 Apr; 519(1):26-33. PubMed ID: 23403233
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor receptor and human epidermal growth factor receptor 2 gene polymorphisms in endometrial cancer in a Japanese population.
Kitao K; Yoshida S; Kennedy S; Takemura N; Sugimoto M; Deguchi M; Ohara N; Maruo T
Reprod Sci; 2007 May; 14(4):349-57. PubMed ID: 17644807
[TBL] [Abstract][Full Text] [Related]
16. Genetic susceptibility of epidermal growth factor +61A>G and transforming growth factor beta1 -509C>T gene polymorphisms with gallbladder cancer.
Vishnoi M; Pandey SN; Modi DR; Kumar A; Mittal B
Hum Immunol; 2008 Jun; 69(6):360-7. PubMed ID: 18571008
[TBL] [Abstract][Full Text] [Related]
17. Association between epidermal growth factor (EGF) and EGF receptor gene polymorphisms and end-stage renal disease and acute renal allograft rejection in a Korean population.
Kim BW; Kim SK; Heo KW; Bae KB; Jeong KH; Lee SH; Kim TH; Kim YH; Kang SW
Ren Fail; 2020 Nov; 42(1):98-106. PubMed ID: 31906817
[No Abstract] [Full Text] [Related]
18. Lack of association between EGF +61A>G polymorphism and melanoma susceptibility in Caucasians: a HuGE review and meta-analysis.
Wu D; Wu Y; Zhang X; Cong P; Lv X
Gene; 2013 Feb; 515(2):359-66. PubMed ID: 23201894
[TBL] [Abstract][Full Text] [Related]
19. Function and clinical relevance of RHAMM isoforms in pancreatic tumor progression.
Choi S; Wang D; Chen X; Tang LH; Verma A; Chen Z; Kim BJ; Selesner L; Robzyk K; Zhang G; Pang S; Han T; Chan CS; Fahey TJ; Elemento O; Du YN
Mol Cancer; 2019 May; 18(1):92. PubMed ID: 31072393
[TBL] [Abstract][Full Text] [Related]
20. Association between EGF +61 genetic polymorphisms and non-small cell lung cancer increased risk in a Portuguese population: a case-control study.
de Mello RA; Ferreira M; Costa S; Costa BM; Pires FS; Neves I; Almeida MI; Cunha J; Oliveira P; Hespanhol V; Reis RM
Tumour Biol; 2012 Oct; 33(5):1341-8. PubMed ID: 22457050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]